Equity Analysis /
United States of America

US : Pharmaceuticals - Specialty Pharmaceuticals | 2021 Starts Strong with Post-Pandemic High; Late 1Q21 Recovery of TRx Volumes Remains Promising

    Lucas Lee
    Lucas Lee

    Sr. Res. Assoc.

    19 January 2021
    Published byCGS-CIMB

    Momentum from the back half of 2020 carried into the start of 2021 as the first week of the year posted TRx levels of 87.6M, a new high since the drop-off in mid-March 2020. Of the past eight weeks, five of them have been highs from the April 2020 bottom, only breaking for shortened holiday weeks.